Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sham-Controlled rTMS for Refractory Depression in Autism Spectrum Disorder

NCT06670040 is registered in ClinicalTrials.gov with Children's Hospital Medical Center, Cincinnati as lead sponsor.

NCT NCT06670040
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06670040 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sham-Controlled rTMS for Refractory Depression in Autism Spectrum Disorder
Lead sponsor
Children's Hospital Medical Center, Cincinnati
Phase
Not applicable
Overall status
Active, not recruiting
Start date
September 16, 2024
Completion date
April 30, 2026
Enrollment
24 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asd, autism, autism spectrum disorder, depression - major depressive disorder, mdd